Income statement
USD
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 46M | 42M | 42M | 32M | 15M |
| Gross Profit | 9M | 2M | 5M | 2M | -5M |
| Operating Income | 4M | 671K | 3M | 744K | -6M |
| EBITDA | 7M | 4M | 6M | 3M | -3M |
| Net Income | -9M | -11M | -13M | -7M | -5M |
| EPS (Diluted) | — | — | — | — | — |
Consumer Cyclical
Live Price
Offline$5.23
+0.00% today
1Y Change
+161.50%
Window
Jun 23, 2025 → Jun 1, 2026
Coverage: 236 bars · Jun 23, 2025 → Jun 1, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Portsmouth Square, Inc. (PRSI) is a Consumer Cyclical stock with listed on OTC. The stock last traded around $5.23 and up 161.5% across the available one-year price window (Jun 23, 2025 → Jun 1, 2026). Baseline metrics include revenue growth of +10.7%, EPS growth of +19.9%, a dividend yield of 0.0%. What stands out right now is revenue +10.7%, EPS +19.9%, free cash flow -13.2% with operating margin 8.3% and ROIC 9.4%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Stock Foundry combines PRSI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PRSI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PRSI Max Drawdown
-46.24%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PRSI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$14.7M
-53.5% YoY
FY Net Income
-$5.3M
+19.5% YoY
Free Cash Flow
-$11.8M
-150.8% YoY
Revenue Growth
+10.7%
EPS Growth
+19.9%
Gross Margin
14.3%
Net Margin
-16.3%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 46M | 42M | 42M | 32M | 15M |
| Gross Profit | 9M | 2M | 5M | 2M | -5M |
| Operating Income | 4M | 671K | 3M | 744K | -6M |
| EBITDA | 7M | 4M | 6M | 3M | -3M |
| Net Income | -9M | -11M | -13M | -7M | -5M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4M | 4M | 2M | 3M | 2M |
| Total Assets | 47M | 41M | 41M | 50M | 53M |
| Total Liabilities | 171M | 156M | 145M | 140M | 136M |
| Shareholder Equity | -124M | -115M | -104M | -90M | -83M |
| Total Debt | 142M | 130M | 126M | 127M | 124M |
| Net Debt | 130M | 126M | 123M | 124M | 121M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
11M
-287.1% YoY
Capital Expenditures
1M
+44.5% YoY
Free Cash Flow
12M
-150.8% YoY
Key ratios
Gross Margin
14.3%
Operating Margin
8.3%
Net Margin
-16.3%
ROE
6.4%
Debt / Equity
-1.10x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.